Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 08:15
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
INDRENEW posted a 0% gross margin in Q3, down from Q2.
The company's marginal operating leverage also remained stable.
On a daily basis, INDRENEW's traded, a decline of 77.7% from the previous day. The stock's price also decreased by 0.6% from the previous day.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 0 % | 0 | - |
| MARGINAL_OPERATING_LEVERAGE | 0 % | 0 | - |
| PRICE_CHANGE_PERCENT | -4.957 % | — | - |
| DAILY_VOLUME | 7,338 shares | 32,183 | ▼ |
| CLOSE_PRICE | 12.08 INR | 12.71 | ▼ |
Cite this
Source: Samhati evidence synthesis for INDRENEW (2026-10-20). Observation: INDRENEW posted a 0% gross margin in Q3, down from Q2. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/indrenew